sunosi
atnahs pharma netherlands b.v. - solriamfetol hydrochlorid - narcolepsy; sleep apnea, obstructive - psychoanaleptics, - sunosi er indiceret til at forbedre vågenhed og reducere overdreven søvnighed i dagtimerne i voksne patienter med narkolepsi (med eller uden katapleksi). sunosi er indiceret til at forbedre vågenhed og reducere overdreven søvnighed i dagtimerne (eds) hos voksne patienter med obstruktiv søvnapnø (osa), hvis eds har ikke været tilfredsstillende, behandlet med primær osa terapi, såsom kontinuerlig positiv luftvejs tryk (cpap).
jinarc
otsuka pharmaceutical netherlands b.v. - tolvaptan - polycystic kidney, autosomal dominant - diuretika, - jinarc er indiceret til at bremse udviklingen af cyste udvikling og nyreinsufficiens af autosomal dominerende polycystisk nyresygdom (adpkd) hos voksne med cementovnstøv fase 1 til 3 på indledning af behandling med beviser for hastigt fremad sygdom.
inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leukæmi, myeloid - antineoplastiske midler - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunosuppressiva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
arikayce liposomal
insmed netherlands b.v. - amikacin sulfate - luftvejsinfektioner - antibakterielle midler til systemisk brug, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - multipel sklerose, recidiverende-remitterende - immunosuppressiva - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
bonviva
atnahs pharma netherlands b.v. - ibandronsyre - osteoporose, postmenopausale - narkotika til behandling af knoglesygdomme - behandling af osteoporose hos postmenopausale kvinder med øget risiko for fraktur (se afsnit 5. en reduktion af risikoen for vertebrale frakturer er blevet påvist, at effekten på lårbenshals brud er ikke blevet oprettet.
tecfidera
biogen netherlands b.v. - dimethylfumarat - multipel sclerose - immunosuppressiva - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
rxulti
otsuka pharmaceutical netherlands b.v. - brexpiprazole - skizofreni - psykoleptika - behandlingen af skizofreni.